arrow
D

David Smil

University of Toronto
H指数:28
被引数:3,018

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer

作为Hippo通路调节剂,用于癌症治疗的强效且选择性的双NUAK/MARK抑制剂的发现与开发

2026-03-310
PRE
Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2
2024-07-180
OAAI
Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics**

选择性PRMT4抑制剂的合理设计和合成: 开发癌症治疗药物的新化学型 **

2021-03-0411
OA
Leveraging an Open Science Drug Discovery Model to Develop CNS-Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma
2020-08-1117
OAAI
Identification and characterization of the first fragment hits for SETDB1 Tudor domain
2019-09-0114
OAAI
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
2019-01-0388
OAAI
Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)

蛋白质精氨酸甲基转移酶3 (PRMT3) 的有效和选择性变构抑制剂的发现

2018-01-0528
OAAI
Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6

发现蛋白质精氨酸甲基转移酶4和蛋白质精氨酸甲基转移酶6的有效,选择性和细胞活性双重抑制剂

2016-09-1569
OAAI
Functional interdependence of BRD4 and DOT1L in MLL leukemia
2016-06-1391
OA
Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1)
2016-03-0981
PREAI
Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor

发现有效的I类蛋白精氨酸甲基转移酶片段抑制剂

2016-01-2932
PREAI
Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia (vol 11, pg 571, 2015 )
2015-09-171
OAAI